Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.

Breast cancer research and treatment - 1 Dec 2022

Shafi Saba, Hu Yan, Parwani Anil V, Ding Qingqing, Li Zaibo

Abstract excerpt

PURPOSE: The recent WHO classification of breast cancer (2019) categorizes breast carcinoma with neuroendocrine (NE) differentiation into three morphologically distinct subtypes: well-differentiated neuroendocrine tumor (NET), poorly differentiated neuroendocrine carcinoma (NEC), and invasive breast carcinoma, no special type with neuroendocrine differentiation (IBC-NST-NE). Data regarding the prognostic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Carcinoma, Neuroendocrine

Share to Mutation

Share to Neuroendocrine Tumors

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 36260193
DOI: 10.1007/s10549-022-06766-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Comprehensive analysis of clinicopathologic features and p53 mutation in neuroendocrine neoplasms of the breast: experience from a large academic center.PMID 36260193Read ↗

Comprehensive Analysis of Clinicopathologic Features and p53 Mutation in Neuroendocrine Neoplasms of the Breast: Experience from a Large Academic CenterSemantic proximity Read ↗

Neuroendocrine tumours of the breast: a genomic comparison with mucinous breast cancers and neuroendocrine tumours of other anatomic sites.Semantic proximity Read ↗

RB1 Genetic Alterations in Estrogen Receptor-Positive Breast Carcinomas: Correlation With Neuroendocrine Differentiation.Semantic proximity Read ↗

The Mutational, Prognostic, and Therapeutic Landscape of Neuroendocrine Neoplasms.Semantic proximity Read ↗

The genetic landscape of breast carcinomas with neuroendocrine differentiation.Semantic proximity Read ↗

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot StudySemantic proximity Read ↗

Genetic alterations of GI-NECs involving three main signaling pathways.Semantic proximity Read ↗

Genomic Profiling and Clinicopathological Characteristics of Neuroendocrine Tumors of the Lung in East Asian Patients.Semantic proximity Read ↗

Neuroendocrine carcinoma and mixed neuroendocrine‒non-neuroendocrine neoplasm of the stomach: a clinicopathological and exome sequencing study.Semantic proximity Read ↗

Progression of low-grade neuroendocrine tumors (NET) to high-grade neuroendocrine neoplasms harboring the prototypical neuroendocrine carcinoma (NEC) co-alteration of RB1 and TP53.Semantic proximity Read ↗

Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma.Semantic proximity Read ↗

Histopathologic and genetic distinction of well-differentiated grade 3 neuroendocrine tumor versus poorly-differentiated neuroendocrine carcinoma in high-grade neuroendocrine neoplasms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.